Nucleic acid nanoparticles (NANPs) have found success in a variety of biochemical applications ranging from nanoscaffolds for coordinated delivery of multiple therapeutic nucleic acids (TNAs) to potent immunoregulators and biosensors. Despite their potential, the true viability of NANPs and TNAs is limited by their relative chemical instability and sensitivity to higher temperatures. Shipping and transportation of NANPs and TNAs currently relies on a cold-chain storage. Newly developed ...